BDH Pharma

Curated by Signal

Developer of cannabinoid therapeutics for multiple indications

Overview

Developer of cannabinoid therapeutics for multiple indications. The lead candidate BDH-001 is a cannabinoid-based analgesic used for the treatment of chronic pain, opioid use disorder, and opioid withdrawal.

Key facts

Founded: 2017
Headquarters: Los Angeles, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Primary office: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Mindhanced
Information portal focused on brain health
Health TechnologyMiami Beach, United States
Floodlight Open
Provider of an online platform to monitor the symptoms of multiple sclerosis
Health TechnologyNew York City, United States
PharmaSecure
SMS-based medication authenticity verification platform
Health TechnologyNew York City, United States

About BDH Pharma

What does BDH Pharma do?

Developer of cannabinoid therapeutics for multiple indications.

Where is BDH Pharma headquartered?

BDH Pharma is headquartered in Los Angeles, United States.

When was BDH Pharma founded?

BDH Pharma was founded in 2017.

Which sector is BDH Pharma in?

BDH Pharma operates in Health Technology.

Who are BDH Pharma's competitors?

Companies similar to BDH Pharma include Mindhanced, Floodlight Open, and PharmaSecure.